Presentation and Management of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)

Thursday, December 20, 2018, 12:00 AM - Monday, January 1, 2024, 12:00 AM, Online Course

Internet Enduring Material Sponsored by the Stanford University School of Medicine. Presented by the Departments of Pediatrics and Psychiatry and Behavioral Health at the Stanford University School of Medicine.

This CME activity provides a practical approach to the recognition and management of Pediatric Acute-Onset Neuropsychiatric Syndrome, also referred to as PANS. PANS is relatively newly understood, under-identified, and therefore under-treated in clinical practice. In PANS, “medical” infectious and inflammatory diseases present with severe, often debilitating “mental” psychiatric and neurological symptoms. When the connections between infection, inflammation and PANS symptoms are not suspected and identified, the opportunity for clinical treatment may be missed or delayed.  During this course, typical presentations will be illustrated with case scenarios. Different aspects of evaluation will be demonstrated, including physical examination for neurological soft signs. Treatment algorithms will also be demonstrated, and the role of family education, multidisciplinary coordination and need for school accommodations will be discussed.

Intended Audience

This course is designed to meet the educational needs of physicians from a wide variety of specialties including primary care, family practice, pediatrics, neurology, psychiatry, and other specialties such as pediatric emergency care, adolescent medicine, pediatric neurology, pediatric otolaryngology, pediatric allergy/immunology, pediatric rheumatology, pediatric hospitalist, pediatric urology and pediatric sleep medicine.

  Release Date: December 20, 2018
  Latest Review Date: December 20, 2021
  Expiration Date: January 01, 2024
  Estimated Time to Complete:  1.75 hours
  Registration Fee: FREE

Click Begin (at the top) to learn more about how to enroll in the course.

IMPORTANT: This course is currently unavailable due to a technical issue. We apologize for any inconvenience caused.

AMA PRA Category 1 Credits™ (1.75 hours), Non-Physician Participation Credit (1.75 hours)

1. Recognize the signs and symptoms of PANS in patients.
2. Administer the appropriate first line treatments to PANS patients.
3. Effectively refer PANS patients to specialist care and coordinate care with these healthcare providers.
4. Educate and counsel PANS patients and their families on care at home and at school.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 1.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cultural and Linguistic Competency

The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws. You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Bibliography

Clinical Evaluation of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference https://www.liebertpub.com/doi/10.1089/cap.2014.0084

Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I—Psychiatric and Behavioral Interventions https://www.liebertpub.com/doi/10.1089/cap.2016.0145

Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II—Use of Immunomodulatory Therapies https://www.liebertpub.com/doi/10.1089/cap.2016.0148

For a complete list, please view the References/Bibliography page in the Course.

Disclosures
The following planner and speaker has indicated that she has no relationships with industry to disclose relative to the content of this activity:

Stanford University School of Medicine has received and has used undesignated program funding from Pfizer, Inc. to facilitate the development of innovative CME activities designed to enhance physician competence and performance and to implement advanced technology. A portion of this funding supports this activity.